Stay updated on MPS IIIB Gene Transfer Clinical Trial
Sign up to get notified when there's something new on the MPS IIIB Gene Transfer Clinical Trial page.
Latest updates to the MPS IIIB Gene Transfer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe bottom of the page now displays revision v3.3.2, replacing the previous v3.3.1. This is a minor site update that does not alter study content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check21 days agoChange DetectedA note stating that PubMed publications are auto-filled and may not all pertain to the study was added, and the page revision updated to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check29 days agoChange DetectedRemoval of the government funding/operating status notice from the page. The study details remain unchanged.SummaryDifference0.4%
- Check43 days agoChange DetectedThe study record now shows Terminated status with a note that Abeona is discontinuing development for ABO-101 due to drug supply and business reasons. Enrollment and other study details are updated to reflect termination.SummaryDifference0.5%
- Check71 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference3%
- Check79 days agoChange DetectedCore content and proper noun corrections: standardizes the disease name to Mucopolysaccharidosis type 3B and updates the revision to v3.1.0.SummaryDifference0.1%
Stay in the know with updates to MPS IIIB Gene Transfer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MPS IIIB Gene Transfer Clinical Trial page.